Abstract
In the last ten years, the paradigm of open innovation has modified the way in which the research and development process is organised and managed by high-technology firms. However, this model should be adapted to the specific characteristics and conditions of each industrial sector. Using the data collected through interviews with 23 managers of UK biopharmaceutical SMEs, this study attempts to identify the factors that may enhance the capacity of these firms to develop and manage open innovation systems. Findings indicate that the size of the firm, its organisational stage, its capability to develop partnerships and its capacity to identify partner organisations with complementary resources influence the capacity of the biopharmaceutical organisation to implement and manage open innovation systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Entrepreneurial Venturing
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
